Post Market Clinical Follow-up of EUROSTEM Femoral Stem

Euros

Status: Active, not recruiting

Conditions: Hip Fractures; Hip Arthropathy; Hip Osteoarthritis; Hip Dysplasia; Hip Necrosis; Hip Arthritis

Treatments: Device: hip arthroplasty

Study type: Observational

Funder types: Industry

Identifiers

NCT04995822

EC-309-01

Details and patient eligibility

About

EUROSSTEM is intended for use in primary and revision total hip replacement surgery.

Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.

As part of post market vigilance, EUROS will collect data on EUROSTEM performances and safety

Full description

Post market observational study. This study is multicenter, prospective, non comparative.

Enrollment: 131 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient who received EUROSTEM
• Patient informed of its participation to the study
• Patient aged over 18 to date of surgery

Exclusion criteria

• Patient presenting a contraindication to EUROSTEM implantation.
• Patient who refused to participate to the study
• Vulnerable subjects

Trial design

131 participants in 1 patient group

EUROSTEM femoral stem

Description:

All patients who received EUROSTEM femoral stem whatever the version (cemented or cementless)

Treatment:

Device: hip arthroplasty